ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 82 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $81,000 | -14.7% | 24,210 | -9.3% | 0.00% | – |
| Q4 2020 | $95,000 | +58.3% | 26,703 | -18.5% | 0.00% | – |
| Q2 2020 | $60,000 | +1400.0% | 32,748 | +3018.9% | 0.00% | – |
| Q2 2017 | $4,000 | +33.3% | 1,050 | +5.0% | 0.00% | – |
| Q1 2017 | $3,000 | -25.0% | 1,000 | -33.3% | 0.00% | – |
| Q4 2016 | $4,000 | +33.3% | 1,500 | +50.0% | 0.00% | – |
| Q3 2016 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -50.0% | 1,000 | -31.0% | 0.00% | – |
| Q1 2016 | $6,000 | -14.3% | 1,450 | -3.3% | 0.00% | – |
| Q4 2015 | $7,000 | -22.2% | 1,500 | 0.0% | 0.00% | – |
| Q3 2015 | $9,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |